Sprout Health Solutions
Sprout Health Solutions is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour
Sponsor Synox Therapeutics Limited
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-demand Treatment of Angioedema Attacks in Adults with Acquired Angioedema due to C1 Inhibitor Deficiency
Sponsor Pharvaris Netherlands B.V.
- Start (EU)
- Latest update
- Estimated end
A Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of Topically Applied TCP-25 in Patients with Epidermolysis Bullosa
Sponsor Xinnate AB
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Sprout Health Solutions?
The 2026-10-09 snapshot links Sprout Health Solutions to 3 distinct CTIS trials. Recorded services include Analysis of transcripts from Audio Recordings for 6M and 12M Subject Qualitative Exit Interviews (Subset of subjects in specific countries), exit interviews, Qualitative Interviews. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sprout Health Solutions?
The most frequently recorded therapeutic areas are Allergy, Immunology, Musculoskeletal, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sprout Health Solutions conducted?
The linked trials record locations in 12 countries, including Spain, France, Italy, Austria, Netherlands. These are trial locations, not confirmed office locations or countries where Sprout Health Solutions delivered services.
What can this page tell me about Sprout Health Solutions's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sprout Health Solutions. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sprout Health Solutions Limited